Giorgia Grassi, Alberto Ghielmetti, Marta Zampogna, Iacopo Chiodini, Maura Arosio, Giovanna Mantovani, Cristina Eller-Vainicher
{"title":"回应:Fitzpatrick 等人致编辑的信:\"停用地诺单抗后使用唑来膦酸钠:重复给药是否比单次输注更有效?","authors":"Giorgia Grassi, Alberto Ghielmetti, Marta Zampogna, Iacopo Chiodini, Maura Arosio, Giovanna Mantovani, Cristina Eller-Vainicher","doi":"10.1210/clinem/dgae493","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":50238,"journal":{"name":"Journal of Clinical Endocrinology & Metabolism","volume":" ","pages":"e2360-e2361"},"PeriodicalIF":5.0000,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Response to: Letter to the Editor From Fitzpatrick et al: \\\"Zoledronate After Denosumab Discontinuation: Is Repeated Administrations More Effective Than Single Infusion?\\\"\",\"authors\":\"Giorgia Grassi, Alberto Ghielmetti, Marta Zampogna, Iacopo Chiodini, Maura Arosio, Giovanna Mantovani, Cristina Eller-Vainicher\",\"doi\":\"10.1210/clinem/dgae493\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":50238,\"journal\":{\"name\":\"Journal of Clinical Endocrinology & Metabolism\",\"volume\":\" \",\"pages\":\"e2360-e2361\"},\"PeriodicalIF\":5.0000,\"publicationDate\":\"2024-11-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Clinical Endocrinology & Metabolism\",\"FirstCategoryId\":\"88\",\"ListUrlMain\":\"https://doi.org/10.1210/clinem/dgae493\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Endocrinology & Metabolism","FirstCategoryId":"88","ListUrlMain":"https://doi.org/10.1210/clinem/dgae493","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
Response to: Letter to the Editor From Fitzpatrick et al: "Zoledronate After Denosumab Discontinuation: Is Repeated Administrations More Effective Than Single Infusion?"
期刊介绍:
The Journal of Clinical Endocrinology & Metabolism is the world"s leading peer-reviewed journal for endocrine clinical research and cutting edge clinical practice reviews. Each issue provides the latest in-depth coverage of new developments enhancing our understanding, diagnosis and treatment of endocrine and metabolic disorders. Regular features of special interest to endocrine consultants include clinical trials, clinical reviews, clinical practice guidelines, case seminars, and controversies in clinical endocrinology, as well as original reports of the most important advances in patient-oriented endocrine and metabolic research. According to the latest Thomson Reuters Journal Citation Report, JCE&M articles were cited 64,185 times in 2008.